Evaluating the Efficacy and Safety of of HSK44459 in People With Progressive Pulmonary Fibrosis

NCT07503587 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

378

Enrollment

INDUSTRY

Sponsor class

Conditions

Progressive Pulmonary Fibrosis

Interventions

DRUG: HSK44459
DRUG: Placebo

Sponsor

Haisco Pharmaceutical Group Co., Ltd.